Medicare Enrolled

Dr. Anna Pudinak, M.D

Family Medicine · Clifton, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1135 CLIFTON AVE, Clifton, NJ 07013
8624143335
In practice since 2012 (14 years)
NPI: 1952665200 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pudinak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pudinak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pudinak

Dr. Anna Pudinak is a family medicine specialist in Clifton, NJ, with 14 years of NPI registration. Based on federal Medicare data, Dr. Pudinak performed 617 Medicare services across 366 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pudinak received a total of $17,887 from 63 pharmaceutical and/or device companies across 1065 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pudinak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 50% volume in NJ $17,887 industry payments

Medicare Practice Summary

Medicare Utilization ↗
617
Medicare services
Top 50% in NJ for family medicine
366
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~44 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
232 $68 $203
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
71 $63 $124
Obesity behavioral counseling, 15 minutes
A 15-minute face-to-face session focused on behavioral counseling to help manage obesity.
59 $28 $73
Annual alcohol misuse screening, 5 to 15 minutes 55 $21 $48
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
49 $142 $307
Blood glucose level test
A test that measures the amount of sugar in your blood.
47 $4 $35
Annual intensive behavioral therapy for cardiovascular disease, 15 minutes
A yearly, in-person session focused on intensive behavioral therapy to help manage cardiovascular disease. The session lasts for 15 minutes and is conducted with the patient individually.
47 $28 $69
Annual depression screening 42 $21 $51
Advance care planning consultation, first 30 min
A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion.
15 $67 $212
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$17,887
Total received (2018-2024)
Avg $2,555/year across 7 years
Top 2% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
1,065
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,526 (92.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,360 (7.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,035
2023
$3,228
2022
$2,123
2021
$3,441
2020
$2,222
2019
$2,550
2018
$1,287

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,122
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$342
AstraZeneca Pharmaceuticals LP
$255
Boehringer Ingelheim Pharmaceuticals, Inc.
$173
Lilly USA, LLC
$167
Novo Nordisk Inc
$149
PFIZER INC.
$131
Amgen Inc.
$112
Dexcom, Inc.
$87
Teva Pharmaceuticals USA, Inc.
$78
Tolmar, Inc.
$64
Abbott Laboratories
$47
Azurity Pharmaceuticals, Inc.
$46
Bayer Healthcare Pharmaceuticals Inc.
$36
Kowa Pharmaceuticals America, Inc.
$32
Astellas Pharma US Inc
$19
Xeris Pharmaceuticals, Inc.
$19
GlaxoSmithKline, LLC.
$18
Novartis Pharmaceuticals Corporation
$17
ALK-Abello, Inc
$16
Janssen Pharmaceuticals, Inc
$15
IBSA Pharma Inc.
$15
Currax Pharmaceuticals LLC
$15
Ardelyx, Inc.
$15
IRONWOOD PHARMACEUTICALS, INC
$15
Exeltis, USA Inc.
$14
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 56.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$2,395
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,106
Novo Nordisk Inc
$1,995
Biohaven Pharmaceuticals, Inc.
$1,360
Amgen Inc.
$1,326
Lilly USA, LLC
$1,297
AbbVie Inc.
$648
Janssen Pharmaceuticals, Inc
$599
Teva Pharmaceuticals USA, Inc.
$566
Allergan Inc.
$504
Allergan, Inc.
$495
AstraZeneca Pharmaceuticals LP
$468
Ironwood Pharmaceuticals, Inc
$365
ALK-Abello, Inc
$257
Mannkind Corporation
$212
Bayer HealthCare Pharmaceuticals Inc.
$200
Boehringer Ingelheim Pharmaceuticals, Inc.
$200
Takeda Pharmaceuticals U.S.A., Inc.
$187
PFIZER INC.
$173
Bayer Healthcare Pharmaceuticals Inc.
$150
IMPEL PHARMACEUTICALS INC.
$146
Tolmar, Inc.
$142
Esperion Therapeutics, Inc.
$139
Biohaven Pharmaceutical Holding Company Ltd.
$137
GlaxoSmithKline, LLC.
$135
Bard Peripheral Vascular, Inc.
$125
Dexcom, Inc.
$114
Amarin Pharma Inc.
$111
Abbott Laboratories
$103
AngioDynamics, Inc.
$102
SANOFI-AVENTIS U.S. LLC
$95
Horizon Therapeutics plc
$80
Supernus Pharmaceuticals, Inc.
$75
MannKind Corporation
$63
Scilex Pharmaceuticals Inc.
$61
Azurity Pharmaceuticals, Inc.
$61
Novartis Pharmaceuticals Corporation
$54
IRONWOOD PHARMACEUTICALS, INC
$52
Currax Pharmaceuticals LLC
$47
Genentech USA, Inc.
$39
Xeris Pharmaceuticals, Inc.
$38
ARBOR PHARMACEUTICALS, INC.
$38
Ardelyx, Inc.
$33
Kowa Pharmaceuticals America, Inc.
$32
VIVUS LLC
$32
Daiichi Sankyo Inc.
$31
DERMIRA, INC.
$30
IBSA Pharma Inc.
$28
SCILEX PHARMACEUTICALS INC.
$28
SANOFI PASTEUR INC.
$20
Astellas Pharma US Inc
$19
Biogen, Inc.
$18
Medicure Pharma Inc.
$17
Boston Scientific Corporation
$16
EPI Health, LLC
$15
Collegium Pharmaceutical, Inc.
$15
VistaPharm, Inc.
$14
Exeltis, USA Inc.
$14
GE HealthCare
$14
Alfasigma USA, Inc.
$13
Gilead Sciences, Inc.
$13
GE HEALTHCARE
$11
VIVUS, Inc.
$11
Top 3 companies account for 36.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · Aimovig · Amitiza · Austedo XR · BASAGLAR · BOTOX · BOTOX THERAPEUTIC · BYSTOLIC · Bensal HP · CONTRAVE · CREON · DUEXIS · Descovy · Dexcom G6 Transmitter · ELYXYB - celecoxib · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · Grastek · HORIZANT · IBSRELA · INJECTAFER · INVOKANA · JARDIANCE · JATENZO · Kerendia · LICART · LINZESS · Linzess · Lutonix Drug Coated Balloon · MOTEGRITY · MOUNJARO · NEXLETOL · NEXLIZET · NUCALA · NURTEC ODT · ONZETRA XSAIL · Odactra · Otezla · Ozempic · PAXLOVID · Prolia · QBREXZA · QSYMIA · QULIPTA · RAYOS · REYVOW · RYBELSUS · Repatha · Rybelsus · SLYND · SOLIQUA 100/33 · SPINRAZA · SPRAVATO · SYMBICORT · Saxenda · TOUJEO · TRELEGY ELLIPTA · TROKENDI XR · TRULANCE · TRULICITY · Thyquidity · Tirosint · Tresiba · Trudhesa · UBRELVY · VIBERZI · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XOLAIR · Xofluza · ZEPBOUND · ZORYVE · ZTLido · ZYPITAMAG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in NJ.

Looking for a family medicine specialist in Clifton?
Compare family medicine physicians in the Clifton area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,986
Per 100K population
576.1
County median income
$87,137
Nearest hospital
ST JOSEPH'S UNIVERSITY MEDICAL CENTER INC
2.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pudinak is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 2% of NJ peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pudinak experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Pudinak performed 232 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pudinak receive payments from pharmaceutical companies?
Yes. Dr. Pudinak received a total of $17,887 from 63 companies across 1,065 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pudinak's costs compare to other family medicine physicians in Clifton?
Dr. Pudinak's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pudinak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →